This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
296d
From Proteopedia
|
SEQUENCE-DEPENDENT EFFECTS IN DRUG-DNA INTERACTION: THE CRYSTAL STRUCTURE OF HOECHST 33258 BOUND TO THE D(CGCAAATTTGCG)2 DUPLEX
Overview
The bis-benzimidazole drug Hoechst 33258 has been co-crystallized with the, dodecanucleotide sequence d(CGCAAATTTGCG)2. The structure has been solved, by molecular replacement and refined to an R factor of 18.5% for 2125, reflections collected on a Xentronics area detector. The drug is bound in, the minor groove, at the five base-pair site 5'-ATTTG and is in a unique, orientation. This is displaced by one base pair in the 5' direction, compared to previously-determined structures of this drug with the, sequence d(CGCGAATTCGCG)2. Reasons for this difference in behaviour are, discussed in terms of several sequence-dependent structural features of, the DNA, with particular reference to differences in propeller twist and, minor-groove width.
About this Structure
296D is a Protein complex structure of sequences from [1] with as ligand. Full crystallographic information is available from OCA.
Reference
Sequence-dependent effects in drug-DNA interaction: the crystal structure of Hoechst 33258 bound to the d(CGCAAATTTGCG)2 duplex., Spink N, Brown DG, Skelly JV, Neidle S, Nucleic Acids Res. 1994 May 11;22(9):1607-12. PMID:7515488
Page seeded by OCA on Tue Jan 29 17:51:15 2008
